Spine
-
Retrospective propensity-score matched, case control study at 2 academic tertiary care centers. ⋯ Treatment Benefits, Level III.
-
Secondary data analysis of the NIH sponsored study on Adult Symptomatic Lumbar Scoliosis (ASLS). ⋯ Operative treatment was more cost-effective than non-operative treatment for ASLS at eight-year follow-up. The ICER continued to improve as compared to the five-year values ($20,569 vs. $44,033).
-
The present study followed the reporting guidelines for systematic reviews and meta-analyses. ⋯ AI is highly valuable for diagnosing LSS. However, further external validation is necessary to enhance the analysis of different stenosis categories and improve the diagnostic accuracy for mild to moderate stenosis levels.
-
Retrospective cohort study. ⋯ Following IL and TF-CESI, adverse events are relatively rare but not absent. Although the odds of the majority of individual neurologic adverse events were found to be similar, both approaches were independently associated with specific complications. Providers should therefore recognize that, at the national level, one CESI approach may not be universally associated with a lower risk of complications.